Clinical trial
Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
NCT01141686 is registered in ClinicalTrials.gov with Taipei Medical University WanFang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
- Lead sponsor
- Taipei Medical University WanFang Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- December 31, 2009
- Enrollment
- 90 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer